MIRA Pharmaceuticals, Valuation
| MIRA Stock | 1.15 0.07 5.74% |
Today, the firm appears to be undervalued. MIRA Pharmaceuticals, secures a last-minute Real Value of USD3.84 per share. The latest price of the firm is USD1.15. Our model forecasts the value of MIRA Pharmaceuticals, from inspecting the firm fundamentals such as current valuation of 15.52 M, and Return On Equity of -1.92 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting MIRA Pharmaceuticals,'s valuation include:
Undervalued
Today
Please note that MIRA Pharmaceuticals,'s price fluctuation is very risky at this time. Calculation of the real value of MIRA Pharmaceuticals, is based on 3 months time horizon. Increasing MIRA Pharmaceuticals,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MIRA Pharmaceuticals, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MIRA Stock. However, MIRA Pharmaceuticals,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.15 | Real 3.84 | Target 12.08 | Hype 1.15 | Naive 1.26 |
The real value of MIRA Stock, also known as its intrinsic value, is the underlying worth of MIRA Pharmaceuticals, Company, which is reflected in its stock price. It is based on MIRA Pharmaceuticals,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MIRA Pharmaceuticals,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MIRA Pharmaceuticals, Common helps investors to forecast how MIRA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MIRA Pharmaceuticals, more accurately as focusing exclusively on MIRA Pharmaceuticals,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use MIRA Pharmaceuticals,'s intrinsic value based on its ongoing forecasts of MIRA Pharmaceuticals,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against MIRA Pharmaceuticals,'s closest peers. If more than one evaluation category is relevant for MIRA Pharmaceuticals, we suggest using both methods to arrive at a better estimate.
MIRA Pharmaceuticals, Cash |
|
MIRA Valuation Trend
Comparing MIRA Pharmaceuticals,'s enterprise value against its market capitalization is a good way to estimate the value of MIRA Pharmaceuticals, Common uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
MIRA Pharmaceuticals, Total Value Analysis
MIRA Pharmaceuticals, Common is now projected to have valuation of 15.52 M with market capitalization of 20.2 M, debt of 5.06 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the MIRA Pharmaceuticals, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.52 M | 20.2 M | 5.06 K |
MIRA Pharmaceuticals, Asset Utilization
One of the ways to look at asset utilization of MIRA is to check how much profit was generated for every dollar of assets it reports. MIRA Pharmaceuticals, Common secures a negative usage of assets of -0.81 %, losing USD0.008127 for each dollar of assets held by the firm. Ineffective asset utilization conveys that the company is being less competent with each dollar of assets it secures. Strictly speaking, asset utilization of MIRA Pharmaceuticals, Common shows how unsuccessful it operates for each dollar spent on its assets.MIRA Pharmaceuticals, Ownership Allocation
MIRA Pharmaceuticals, maintains a total of 16.56 Million outstanding shares. MIRA Pharmaceuticals, Common holds noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.MIRA Pharmaceuticals, Profitability Analysis
Net Loss for the year was (11.98 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MIRA Pharmaceuticals,'s worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MIRA Pharmaceuticals, and how it compares across the competition.
About MIRA Pharmaceuticals, Valuation
The stock valuation mechanism determines MIRA Pharmaceuticals,'s current worth on a weekly basis. Our valuation model uses a comparative analysis of MIRA Pharmaceuticals,. We calculate exposure to MIRA Pharmaceuticals,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MIRA Pharmaceuticals,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -7.7 M | -8.1 M |
MIRA Pharmaceuticals, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 18.6 M |
MIRA Pharmaceuticals, Current Valuation Indicators
Valuation refers to the process of determining the present value of MIRA Pharmaceuticals, Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value MIRA we look at many different elements of the entity such as MIRA's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as MIRA Pharmaceuticals,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use MIRA Pharmaceuticals,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes MIRA Pharmaceuticals,'s worth.Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |